We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+11.2%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.4M
AUM Growth
+$29.6M
(+44%)
Cap. Flow
+$25.4M
Cap. Flow
% of AUM
26.31%
Top 10 Holdings %
Top 10 Hldgs %
16.71%
Holding
393
New
214
Increased
20
Reduced
17
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$2.19M |
| 2 |
OSG
Overseas Shipholding Group Inc.
OSG
|
+$2.01M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$1.75M |
| 4 |
Cannae Holdings
CNNE
|
+$1.54M |
| 5 |
GeoPark
GPRK
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.06M |
| 2 |
ESMT
EngageSmart, Inc.
ESMT
|
+$1.03M |
| 3 |
TGH
Textainer Group Holdings limited
TGH
|
+$1.02M |
| 4 |
AYX
Alteryx Inc
AYX
|
+$1.01M |
| 5 |
Oracle
ORCL
|
+$964K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.11% |
| 2 | Consumer Discretionary | 18.09% |
| 3 | Energy | 12.35% |
| 4 | Technology | 11.84% |
| 5 | Healthcare | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EB
201
DELISTED
Eventbrite
EB
| $172K | 0.18% |
+31,311
| New | +$227K |
|
202
Pan American Silver
PAAS
$21.6B
| $171K | 0.18% |
+11,307
| New | +$156K |
|
203
American Healthcare REIT
AHR
$10.9B
| $168K | 0.17% |
+11,407
| New | +$157K |
|
204
Oric Pharmaceuticals
ORIC
$1.4B
| $161K | 0.17% |
+11,689
| New | +$139K |
|
|
FFIC
205
DELISTED
Flushing Financial
FFIC
| $160K | 0.17% |
+12,654
| New | +$178K |
|
206
Magnachip Semiconductor
MX
$145M
| $159K | 0.17% |
+28,505
| New | +$182K |
|
207
The Honest Company
HNST
$586M
| $147K | 0.15% |
+36,339
| New | +$123K |
|
208
Kearny Financial
KRNY
$599M
| $146K | 0.15% |
+22,736
| New | +$159K |
|
209
SEACOR Marine Holdings
SMHI
$258M
| $144K | 0.15% |
+10,341
| New | +$120K |
|
210
Weave Communications
WEAV
$423M
| $142K | 0.15% |
+12,410
| New | +$149K |
|
211
OraSure Technologies
OSUR
$279M
| $141K | 0.15% |
+22,868
| New | +$166K |
|
212
Neumora Therapeutics
NMRA
$302M
| $138K | 0.14% |
+10,000
| New | +$162K |
|
213
Resources Connection
RGP
$145M
| $134K | 0.14% |
+10,202
| New | +$136K |
|
214
Relay Therapeutics
RLAY
$4.33B
| $133K | 0.14% |
+16,018
| New | +$156K |
|
215
Backblaze
BLZE
$1.16B
| $132K | 0.14% |
+12,910
| New | +$119K |
|
216
National CineMedia
NCMI
$378M
| $129K | 0.13% |
+24,997
| New | +$106K |
|
217
B2Gold
BTG
$6.64B
| $128K | 0.13% |
+49,199
| New | +$133K |
|
|
DCH
218
Dauch Corp
DCH
$1.51B
| $126K | 0.13% |
+17,155
| New | +$129K |
|
|
DNB
219
DELISTED
Dun & Bradstreet
DNB
| $123K | 0.13% |
+12,270
| New | +$134K |
|
|
RAPT
220
DELISTED
RAPT Therapeutics
RAPT
| $122K | 0.13% |
+1,699
| New | +$236K |
|
221
AngioDynamics
ANGO
$649M
| $121K | 0.13% |
+20,688
| New | +$123K |
|
|
AAN
222
DELISTED
The Aaron's Company Inc
AAN
| $116K | 0.12% |
+15,449
| New | +$145K |
|
223
Summit Therapeutics
SMMT
$11.1B
| $112K | 0.12% |
+27,080
| New | +$108K |
|
224
Chegg
CHGG
$102M
| $110K | 0.11% |
+14,586
| New | +$134K |
|
225
Cogent Biosciences
COGT
$7.24B
| $106K | 0.11% |
+15,808
| New | +$97.7K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Oxford Asset Management held 393 positions worth $96.4M, up 44% from $66.8M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Oxford Asset Management deployed $25.4M of net new capital in Q1 2024, opening 214 new positions and adding to 20 existing holdings. Its largest new stake was Stellantis: 88,000 shares worth $2.49M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Micron Technology, an estimated $705K trimmed.
- Oxford Asset Management's largest Q1 2024 buy was Stellantis: 88,000 shares worth $2.49M.
- Oxford Asset Management added most to Daseke, Inc. Common Stock in Q1 2024, an estimated $624K increase.
- Oxford Asset Management's biggest Q1 2024 reduction was Micron Technology, cutting an estimated $705K.
- Oxford Asset Management fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $1.06M.
- Oxford Asset Management's ten largest holdings make up 17% of its $96.4M portfolio in Q1 2024.
- Oxford Asset Management opened 214 new positions and closed 138 in Q1 2024.
- Oxford Asset Management's portfolio value rose 44% quarter-over-quarter to $96.4M.
Based on Oxford Asset Management's 13F filing for Q1 2024, filed 15 May 2024.